Day One (13th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
- Bjarne Rask Poulsen, PhD - Cell Culture Specialist, Novo Nordisk
- Alexander Doerfler - Senior Expert Science and Technology, Biostatistician, Novartis
- Shan-Hua Chung - Principal Scientist and Matrix Lead in Cell Technologies, Roche
- David Öling - Director, Molecular Biology and Recombinant Protein Production, AstraZeneca
- A Representative from BioPhorum - -, BioPhorum
- Sebastian Schwaminger - Associate Professor, Medical University of Graz
- Christian Witz - CEO, SimVantage GmbH
- Moo Sun Hong - Assistant Professor, Seoul National University
- Ignasi Bofarull-Manzano - Industrial PhD Candidate, CMC Data Scientist and Consultant, RWTH Aachen University, Körber Pharma
- Jenny Ann Prange - Head of Production, CTO and Co-founder, MUVON Therapeutics AG
- Vincent Wiegmann - Senior Scientist, MeiraGTx
- Gearóid Duane - Principal Scientist, Manufacturing Science & Technology Upstream, Bristol Myers Squibb, Cruiserath Biologics
- Imke Vohs - Scientist Engineering USP, MSD
- Moritz Schmidt - Head of Laboratory Molecular Biology, Boehringer Ingelheim
- Lasse Ebdrup Pedersen - Associate Professor, The Technical University of Denmark
- Fabian Vogt - Head of Laboratory, Boehringer Ingelheim
- Neil Watson - Principal Scientist, UCB
- Jason Beckwith - Research Group Lead, University of Dundee
- Jason Beckwith - Research Group Lead, University of Dundee
Unique challenges of scaling up CGT manufacturing and how real time analytics can be used to aid in scale up
Implementing PAT (Process Analytical Technology) and other real-time monitoring tools
- Using data to identify and address process deviations proactively
- Building a robust data infrastructure for ATMP manufacturing
Importance of tech transfer:
- How to approach this
- Best practices
- Lior Raviv - Chief Technology Officer, Pluri Biotech Ltd
Join us in the Exhibit Hall for Live Labs.
You'll be taken on a tour of the hall to meet and engage with our exhibitors, hear quick-fire presentations, and into cutting-edge advancements from the exhibitors you visit - don't miss out!
- Simon Fradin - Senior Manager / Lab Head Upstream Process Development, Biopharmaceutical Product Development, Fresenius Kabi
This session will interview a member from a sending and receiving site and identify the pain points from both sides that come with transferring technology and processes. How things have changed, and how they will change in an era of digital transformation and an ever increasing need to simplify.
Data lakes, interrogation and digitalization
Leveraging historical data
Skinny process validation
In this presentation we will discuss key aspects related to rAAV production systems' scalability, addressing challenges and future directions for product characterization. Our research lies in improving stable cell line-based production systems for rAAV production. How to optimise the cell line generation process and improve the cell host by CRISPR-Cas9 genetic screen and single cell RNA-seq approaches will be discussed.
- Jose Miguel Escandell Planells - Principal Scientist, iBET - Instituto de Biologia Experimental e Tecnológica
Recombinant protein expression is a highly regulated process consisting of transcription, translation, and protein folding. CHO-based expression often stays challenging for artificial therapeutic proteins, like Bispecific T-cell Engagers (BiTE®) due to reduced productivity compared to monoclonal antibodies. A differentiated insight into the evaluation of expression steps will be given, as well as strategies to find bottlenecks.
- Benedikt Greck - Doctoral Student, Platformization of Complex Molecules, Amgen
- Patrick Garidel - Global Development CMC Biologicals, Boehringer Ingelheim
- Sofia Carvalho - Senior Scientist, iBET
- Christian Witz - CEO, SimVantage GmbH
- Andrej Pohar - Senior Expert Science & Technology, Novartis
- Mark Duerkop - Chief Executive Officer, Novasign, Austria
- Lior Shaltiel - CEO, NurExone Biologic
- Tiffany Rau, PhD - Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
- Louis Boon, PhD - Chief Scientific Officer and Board Member, JJP Biologics